NCT02940262View on ClinicalTrials.gov

Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy

PHASE3CompletedINTERVENTIONAL

Enrollment

1,138

Participants

Timeline

Start Date

September 15, 2016

Primary Completion Date

June 18, 2021

Study Completion Date

June 18, 2021

Conditions

Prostate AdenocarcinomaRecurrent Prostate Carcinoma

Interventions

RADIATION

Gallium Ga 68 Gozetotide

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Positron Emission Tomography

Undergo PET imaging

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT02940262 - Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy | Biotech Hunter | Biotech Hunter